3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
5
Myeloproliferative Disorders
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Leukemia, Myelomonocytic, Chronic
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
durvalumab
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
guadecitabine
1
fludarabine
1
atezolizumab
1
Taxes
1
Specimen Handling
1
Platinum
1
Oxaliplatin
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Ipilimumab
1
Folfox protocol
1
Fluorouracil
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Injections
×
30 days
×
Clear all
No trials found.